Bayer Ag

Bayer AG to hold off breakup plans despite investor pressure: Report

CEO Bill Anderson, at the helm since June last year, said in November he is weighing options to break apart the diversified company in a staggered fashion but would not rule out keeping all businesses

NPPA to cap medicine prices to boost affordability, curb profiteering

The change could have financial implications for leading drug manufacturers like Abbott Laboratories, Bayer AG, and GlaxoSmithKline, among others

Bayer agrees to settle Roundup cancer lawsuits for up to $10.9 billion

The German drugs and pesticides maker has come to terms with about 75 per cent of the current Roundup plaintiffs

US court blocks Bayer from selling an agricultural weed killer in America

The company faces separate allegations that its glyphosate-based weed killer Roundup causes cancer

Bayer investor sues top executives for 'disastrous' Monsanto deal

Bayer shares are down 31% since the company completed the $63 billion takeover of Monsanto, prompting some investors to demand the resignation of Chief Executive Officer Werner Baumann.

Bayer board backs CEO after unprecedented shareholder rebuke

Baumann suffers defeat with 55% of shareholders in opposition

Bayer defies critics with $62-bn Monsanto offer

To create the world's biggest agricultural supplier

Bayer said to eye bid for $40 bn seed company Monsanto

The firm has held preliminary discussions internally and with advicers; financing, including potential asset sales, also discussed